用单胺氧化酶抑制剂抗抑郁药治疗三环类难治性抑郁症。 - Suppr

Suppr

超能文献

Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.

作者信息

McGrath P J, Stewart J W, Harrison W, Quitkin F M

出版信息

Psychopharmacol Bull. 1987;23(1):169-72.

PMID:3602314

Abstract

摘要

相似文献

Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.用单胺氧化酶抑制剂抗抑郁药治疗三环类难治性抑郁症。

Psychopharmacol Bull. 1987;23(1):169-72.

Triiodothyronine potentiation of the antidepressant effect of phenelzine.

J Clin Psychiatry. 1988 Oct;49(10):409-10.

Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.单胺氧化酶抑制剂（MAOI）或三环类抗抑郁药反应者中与过早停药相关的因素。

J Clin Psychiatry. 1988 May;49(5):196-8.

Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.

J Clin Psychiatry. 1994 Aug;55(8):336-9.

A comparison of phenelzine and imipramine in depressed inpatients.

J Clin Psychiatry. 1981 Oct;42(10):395-7.

Chronic depression: response to placebo, imipramine, and phenelzine.慢性抑郁症：对安慰剂、丙咪嗪和苯乙肼的反应。

J Clin Psychopharmacol. 1993 Dec;13(6):391-6.

Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.溴法罗明治疗抑郁症：一项加拿大多中心安慰剂试验及标准药物对比研究综述

Clin Neuropharmacol. 1993;16 Suppl 2:S51-4.

Differential response patterns to MAO inhibitors and tricyclics.对单胺氧化酶抑制剂和三环类药物的不同反应模式。

J Clin Psychiatry. 1984 Jul;45(7 Pt 2):70-7.

Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.哥伦比亚型非典型抑郁症。这是抑郁症患者中的一个亚组，对单胺氧化酶抑制剂（MAOI）的反应比对三环类抗抑郁药或安慰剂更好。

Br J Psychiatry Suppl. 1993 Sep(21):30-4.

Psychopharmacologic validation of atypical depression.

J Clin Psychiatry. 1984 Jul;45(7 Pt 2):22-5.

引用本文的文献

Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine.对低剂量静脉注射氯胺酮有反应的难治性抑郁症患者的下一步治疗考虑因素

Focus (Am Psychiatr Publ). 2020 Apr;18(2):181-192. doi: 10.1176/appi.focus.20190048. Epub 2020 Apr 23.

Management of Treatment-Resistant Depression: Challenges and Strategies.难治性抑郁症的管理：挑战与策略

Neuropsychiatr Dis Treat. 2020 Jan 21;16:221-234. doi: 10.2147/NDT.S198774. eCollection 2020.

Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.药物治疗抵抗性抑郁症的方法：证据和个人经验。

World J Psychiatry. 2015 Sep 22;5(3):330-41. doi: 10.5498/wjp.v5.i3.330.

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.吗氯贝胺和苯乙肼对单胺氧化酶 -A 的占有率：对单胺氧化酶抑制剂开发的启示

Int J Neuropsychopharmacol. 2015 Aug 27;19(1):pyv078. doi: 10.1093/ijnp/pyv078.

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.如果一开始不成功：抗抑郁药增效、联合和转换策略的证据回顾。

Drugs. 2011 Jan 1;71(1):43-64. doi: 10.2165/11587620-000000000-00000.

Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.急性抑郁发作的药物和联合干预措施：重点关注疗效和耐受性。

Ther Clin Risk Manag. 2009;5:897-910. doi: 10.2147/tcrm.s5751. Epub 2009 Nov 18.

Transdermal selegiline for the treatment of major depressive disorder.透皮用司来吉兰治疗重性抑郁障碍。

Neuropsychiatr Dis Treat. 2007;3(5):527-37.

The role of monoamine oxidase inhibitors in current psychiatric practice.单胺氧化酶抑制剂在当前精神病学实践中的作用。

J Psychiatr Pract. 2004 Jul;10(4):239-48. doi: 10.1097/00131746-200407000-00005.

Antidepressant failure: augmentation or substitution?抗抑郁药治疗失败：增效还是换药？

J Psychiatry Neurosci. 1995 Jan;20(1):7-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验